Search

Search Constraints

You searched for: Author/Creator Jain, Nisha

Search Results

7. Physical activity and bleeding outcomes among people with severe hemophilia on extended half‐life or conventional recombinant factors. Issue 1 (30th December 2020)

9. Real‐world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years. Issue 6 (4th October 2020)

10. Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis. Issue 1 (18th November 2020)